Tom Gayner acquired 49.6k Thermo Fisher Scientific shares worth $24.3M. That's 0.20% of their equity portfolio (78th largest holding). The investor's estimated purchase price is $26.6M, resulting in a loss of 8.8%.
Avg closing price
Price range
Increased shares by 10.1% (+4.55k shares)
Q2 2025
Avg closing price
$417.51
Price range
$390.26
-
$489.06
Increased shares by 9.5% (+3.9k shares)
Q1 2025
Avg closing price
$541.80
Price range
$497.60
-
$606.57
Increased shares by 16.1% (+5.7k shares)
Q4 2024
Avg closing price
$548.87
Price range
$501.50
-
$612.94
Increased shares by 20.4% (+6k shares)
Q3 2024
Avg closing price
$591.45
Price range
$531.86
-
$624.21
Increased shares by 19.0% (+4.7k shares)
Q2 2024
Avg closing price
$572.88
Price range
$541.52
-
$599.02
Increased shares by 26.0% (+5.1k shares)
Q1 2024
Avg closing price
$561.14
Price range
$528.82
-
$599.43
Increased shares by 44.1% (+6k shares)
Q4 2023
Avg closing price
$484.03
Price range
$431.41
-
$532.94
Increased shares by 65.9% (+5.4k shares)
Q3 2023
Avg closing price
$532.87
Price range
$498.29
-
$574.41
Increased shares by 5.1% (+400 shares)
Q4 2022
Avg closing price
$529.89
Price range
$484.71
-
$571.38
Increased shares by 20.0% (+1.3k shares)
Q3 2022
Avg closing price
$559.63
Price range
$507.19
-
$604.49
Increased shares by 233.3% (+4.55k shares)
Q2 2022
Avg closing price
$550.42
Price range
$500.90
-
$612.21
Increased shares by 550.0% (+1.65k shares)
Q1 2022